Marshall Wace’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-58,087
| Closed | -$454K | – | 2751 |
|
2025
Q1 | $454K | Sell |
58,087
-19,381
| -25% | -$151K | ﹤0.01% | 2004 |
|
2024
Q4 | $362K | Sell |
77,468
-2,420
| -3% | -$11.3K | ﹤0.01% | 2026 |
|
2024
Q3 | $431K | Sell |
79,888
-36,028
| -31% | -$194K | ﹤0.01% | 1825 |
|
2024
Q2 | $1.02M | Buy |
115,916
+89,091
| +332% | +$786K | ﹤0.01% | 1522 |
|
2024
Q1 | $315K | Buy |
+26,825
| New | +$315K | ﹤0.01% | 1837 |
|
2022
Q2 | – | Sell |
-67,373
| Closed | -$568K | – | 2924 |
|
2022
Q1 | $568K | Buy |
67,373
+9,991
| +17% | +$84.2K | ﹤0.01% | 2061 |
|
2021
Q4 | $585K | Sell |
57,382
-7,268
| -11% | -$74.1K | ﹤0.01% | 2100 |
|
2021
Q3 | $1.26M | Buy |
+64,650
| New | +$1.26M | 0.01% | 1449 |
|